Osteoporosis in cystic fibrosis;Osteoporose em fibrose cística

Jornal de Pediatria

Volumn 84, Issue 1, 2008, Pages 1-3

  Döring, Gerd ^a   Conway, Steven P ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; TRANSMEMBRANE CONDUCTANCE REGULATOR;

BODY MASS; BODY SIZE; BONE DISEASE; BONE NECROSIS; CORRELATION ANALYSIS; CYSTIC FIBROSIS; DIETARY INTAKE; DUAL ENERGY X RAY ABSORPTIOMETRY; EDITORIAL; ESOPHAGITIS; FORCED EXPIRATORY VOLUME; FRAGILITY FRACTURE; GASTROESOPHAGEAL REFLUX; HOSPITALIZATION; HUMAN; LIFE EXPECTANCY; LUMBAR SPINAL CORD; LUNG FUNCTION; NEWBORN SCREENING; NUTRITIONAL STATUS; OSTEOLYSIS; OSTEOPOROSIS; PNEUMOTHORAX; SOCIAL STATUS; STATISTICAL SIGNIFICANCE; SURVIVAL; UNITED STATES; WEIGHT GAIN;

CYSTIC FIBROSIS; HUMANS; OSTEOPOROSIS;

EID: 39649099731     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.1749     Document Type: Editorial

References (12)

1. Kerem E, Conway S, Elborn S, Heijerman H; Consensus Committee. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros. 2005;4:7-26.
2. Döring G, Hoiby N; Consensus Study Group. Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. J Cyst Fibros. 2004;3:67-91.
3. Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkamp G, Heijerman HG, et al. Nutrition in patients with cystic fibrosis: a European consensus. J Cyst Fibros. 2002;1:51-75.
4. Aris RM, Merkel PA, Bachrach LK, Borowitz DS, Boyle MP, Elkin SL, et al. Guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab. 2005;90:1888-96.
5. Cystic Fibrosis Trust. Bone mineralisation in cystic fibrosis. http://www.cftrust.org.uk/aboutcf/publications/consensusdoc/Bone-Mineral- Booklet.pdf.
6. Conway SP, Morton AM, Oldroyd B, Truscott JG, White H, Smith AH, et al. Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax. 2000;55:798-804.
7. Dif F, Marty C, Baudoin C, de Vernejoul MC, Levi G. Severe osteopenia in CFTR-null mice. Bone. 2004;35:595-603.
8. King SJ, Topliss DJ, Kotsimbos T, Nyulasi IB, Bailey M, Ebeling PR, et al. Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor. Eur Respir J. 2005;25:54-61.
9. Shead EF, Haworth CS, Condliffe AM, McKeon DJ, Scott MA, Compston JE. Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone. Thorax. 2007;62:650-1.
10. Hardin DF, Arumugam R, Seilheimer DK, LeBlanc A, Ellis KJ. Normal bone mineral density in cystic fibrosis. Arch Dis Child. 2001;84:363-8.
11. Buntain HM, Schluter PJ, Bell SC, Greer RM, Wong JC, Batch J, et al. Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis. Thorax. 2006;61:146-54.
12. Caldeira RJ, Fonseca VM, Gomes Junior SC, Chaves CR. Prevalence of bone mineral disease among adolescents with cystic fibrosis . J Pediatr (Rio J). 2008;84(1):18-25.